Emergency Medicine Priority Setting Partnership. PROTOCOL (Version 1: )

Similar documents
Kidney Transplantation

Prostate Cancer Priority Setting Partnership. PROTOCOL June 2009

MS Priority Setting Partnership. PROTOCOL August 2012

Dementia Priority Setting Partnership. PROTOCOL March 2012

Study protocol. Version 1 (06 April 2011) Ethics ref: R&D ref: UK CRC portfolio ID:

1. Purpose of the Pessary PSP and background

1. Purpose of the PSP and background. 2. Aims and objectives of the Psoriasis PSP

1. Purpose of the PSP and background

Hair Loss Priority Setting Partnership

James Lind Alliance Oral and Dental Health Priority Setting Partnership Protocol

1. Purpose of the PSP and background

Establishing and Prioritising Research Questions for the Treatment of Alopecia Areata: The Alopecia Areata Priority Setting Partnership

Version 1.0. Prostate Cancer Priority Setting Partnership

The James Lind Alliance Guidebook

What are some of the future priorities for dementia research?

Measuring the impact of patient and public involvement in the JLA Kidney Transplant PSP

The James Lind Alliance (JLA) Tackling treatment uncertainties together

Affiliates Newsletter April 2009

SETTING PRIORITIES FOR TYPE 1 DIABETES RESEARCH WORKSHOP

Hip and Knee Replacement for Osteoarthritis Priority Setting Partnership

Evaluation of the Type 1 Diabetes Priority Setting Partnership

THE JAMES LIND ALLIANCE Tackling treatment uncertainties together

Palliative and end of life care Priority Setting Partnership

We are currently recruiting new members to advisory groups for the following research programmes:

James Lind Alliance. Tackling treatment uncertainties together (Patients and Clinicians) The Why The What The How The Questions The Future

Prioritising uncertainties assembled in UK DUETs, for additional research. NHS Evidence provided by NICE

HEALTH AND SPORT COMMITTEE AGENDA. 14th Meeting, 2018 (Session 5) Tuesday 1 May 2018

Department of General Practice, National University of Ireland, Galway and Chair of Board of Trustees, Incontact (Action on Incontinence), London

British Association of Stroke Physicians Strategy 2017 to 2020

Report to the Merton Clinical Commissioning Group Governing Body

James Lind Alliance Performance Tracker April 2008 March 2009 Final 20 th April 2009

Beccy Maeso, The James Lind Alliance The James Lind Alliance Perspective

Involving patients in research experiences from the eczema priority setting partnership

Type 2 diabetes Priority Setting Partnership (PSP) FREQUENTLY ASKED QUESTIONS

Adding Value to the NHS, Health and Care, through Research Management, Support & Leadership

White Rose Research Online URL for this paper: Version: Accepted Version

Engaging with our stakeholders

APPENDIX 2. Appendix 2 MoU

Saturday 22 nd October Sally Crowe, Co Chair James Lind Alliance

REGIONAL CONFERENCE FOR LATIN AMERICA AND THE CARIBBEAN (LARC) Thirty-first Session. Panama City, April 2010

Engaging People Strategy

Royal College of Radiologists (RCR) Referral guidelines. Final Accreditation Report. Guidance producer: Guidance product: Date: 29 June 2010

Warrington Health Forum Terms of Reference

JOB DESCRIPTION. ImROC Business Manager (Mental Health Network) and Senior. Policy Manager (NHS Clinical Commissioners)

Patient and Public Involvement in Research

WELSH GOVERNMENT RESPONSE TO RECOMMENDATIONS FROM THE HEALTH & SOCIAL CARE COMMITTEE: INQUIRY INTO NEW PSYCHOACTIVE SUBSTANCES

Family Violence Integration Project. Eastern Community Legal Centre

DRAFT VERSION I SAFEGUARDING CHILDRENS BOARD MARCH 2017 SOUTHWARK PREVENT DRAFT LOCAL DELIVERY PLAN Page 1

Patient and Carer Network. Work Plan

PROMOTING HUMAN ORGAN DONATION AND TRANSPLANTATION IN NORTHERN IRELAND. Consultation Proposals & Response Questionnaire

Steering Group meeting Mild-Moderate hearing loss Priority Setting Partnership

The Palliative and end of life care Priority Setting Partnership with the James Lind Alliance (PeolcPSP)

Research activity following Asthma Treatment Uncertainty Priority Setting Exercise in 2007 paper updated January 2010

Adults and Safer City Scrutiny Panel Minutes - 10 April 2018

ARMA Networks: Induction Pack

Sarah Ambe Team Manager, Healthwatch Bristol SA Alison Bolam GP Clinical Commissioning Area Lead (Bristol), BNSSG AB

Job Profile, Responsibilities and Person Specification

WHY DO WE NEED TO ENGAGE WITH OUR COMMUNITIES?

Committee of Senior Representatives Tenth Meeting Oslo, Norway 11 December 2006

Draft v1.3. Dementia Manifesto. London Borough of Barnet & Barnet Clinical. Autumn 2015

Peer counselling A new element in the ET2020 toolbox

ROLE SPECIFICATION FOR MACMILLAN GPs

NIHR Leeds Clinical Research Facility Patient and Public Involvement Strategy

Solihull Safeguarding Adults Board & Sub-committees

Enhanced CPD Programme Module 1. Introducing Starting Well

CORPORATE PLANS FOR CHILD PROTECTION AND LOOKED ATER CHILDREN AND YOUNG PEOPLE

THE CARDIFF COMMITMENT TO YOUTH ENGAGEMENT AND PROGRESSION: REPORT OF DIRECTOR OF EDUCATION & LIFELONG LEARNING

Funding Opportunities for Public Health Research

Insight. A message from the Director. In this issue

POLICY BRIEFING. Prime Minister s challenge on dementia 2020 implementation plan

SAFE PAEDIATRIC NEUROSURGERY A Report from the SOCIETY OF BRITISH NEUROLOGICAL SURGEONS

Royal College of Physicians (RCP) National Clinical Guidelines for Stroke. Final Accreditation Report. Guidance producer: Guidance product:

Living Evidence Network

Terms of Reference. Tripartite Planning Committee for First Nations & Aboriginal Maternal & Child Health

British Fertility Society. Clinical guidelines

GDm-Health is free to download and use. Its use may result in efficiency savings from reducing face-to-face clinic appointments.

Strategic Plan

How can the patients play their role?

MEMORANDUM OF UNDERSTANDING THE INDEPENDENT FUNDRAISING STANDARDS & ADJUDICATION PANEL FOR SCOTLAND AND THE FUNDRAISING REGULATOR

Appendix 2 Good Relations Action Plan, Outcomes, Timescales

Bristol Parks Forum Terms of Reference

Coventry and Warwickshire Clinical Research Facility Patient and Public Involvement and Engagement Strategy

International Clinical Trials Day is on or around 20 May each year, and commemorates the anniversary of the very first clinical trial by James Lind.

Public Engagement and Public and Patient Involvement. NIHR Newcastle Biomedical Research Centre and Biomedical Research Unit

A Framework for Optimal Cancer Care Pathways in Practice

Royal Borough of Greenwich Safeguarding Adults Board Joint Strategic Plan and Action Plan

Co-ordinated multi-agency support for young carers and their families

Newcastle Safeguarding Children Board Business Group Terms of Reference

What is the impact of the Allied Health Professional Dementia Consultants in Scotland?

Implementing Recovery through Organisational Change. Fiona Houston, Service Improvement Manager 2014

Cancer Improvement Plan Update. September 2014

Volunteering in NHSScotland Developing and Sustaining Volunteering in NHSScotland

HEALTHWATCH AND HEALTH AND WELLBEING BOARDS

Joint FAO/WHO evaluation of the work of the Codex Alimentarius Commission

Mary Madden 1* and Richard Morley 2

Health Scrutiny Panel 6 February 2014

Port of Portland Hillsboro Airport Master Plan Update Planning Advisory Committee Charter

Dementia Advisers Survey

MENTAL HEALTH SERVICE USER INVOLVEMENT Service User Involvement Project Worker The job description does not form part of the contract of employment

Evaluation of the Research Programme in Dementia Care

Transcription:

Emergency Medicine Priority Setting Partnership PROTOCOL (Version 1: 22.10.2015) Purpose The purpose of this protocol is to set out the aims, objectives and commitments of the Emergency Medicine Priority Setting Partnership (PSP) and the basic roles and responsibilities of the partners therein. Steering Group The Emergency Medicine PSP will be led and managed by the following: Patient and carer representatives: o Ben McCullough o Hazel McCullough o Douglas Findlay Cochrane Group o Ian Roberts Clinical representatives: Royal College of Emergency Medicine o Jason Smith o Simon Carley o Liza Keating (deputised by Melanie Gager) o Lynsey Flowerdew Emergency Nursing o Rachel O Brien o Miranda Odam o Katharine Wylie James Lind Alliance: Priority Setting Partnership Protocol 1

o Justine Amero The Partnership and the priority setting process will be supported and guided by: The James Lind Alliance (JLA) o Richard Morley Royal College of Emergency Medicine o Sam McIntyre The Steering Group includes representation of patients, carers and clinicians. The Steering Group will agree the resources, including time and expertise that they will be able to contribute to each stage of the process. The JLA will advise on this. Background to the Emergency Medicine PSP The JLA is a project which is overseen by the National Institute for Health Research Evaluation, Trials and Studies Coordinating Centre (NETSCC). Its aim is to provide an infrastructure and process to help patients and clinicians work together to agree which are the most important treatment uncertainties affecting their particular interest, in order to influence the prioritisation of future research in that area. The JLA defines an uncertainty as a known unknown in this case relating to the effects of treatment. The Emergency Medicine PSP was instigated as a result of an informal priority setting exercise within emergency medicine, and subsequent discussions as to how best approach this issue in the future, ensuing involvement of all the key stakeholders who may have an interest in the future direction of emergency medicine research. Aims and objectives of the Emergency Medicine PSP The aim of the Emergency Medicine PSP is to identify the unanswered questions within emergency medicine from patient and clinical perspectives and then prioritise those that patients and clinicians agree are the most important. The objectives of the Emergency Medicine PSP are to: work with patients and clinicians to identify uncertainties within emergency medicine, covering investigation, diagnosis and management of patients in emergency departments. to agree by consensus a prioritised list of those uncertainties, for future research to publicise the results of the PSP and process to take the results to research commissioning bodies to be considered for funding Partners Organisations and individuals will be invited to take part in the PSP, which represent the following groups: people who have been patients in emergency departments carers of people who have been patients in emergency departments James Lind Alliance: Priority Setting Partnership Protocol 2

medical doctors, nurses and professionals allied to medicine with clinical experience of working in emergency medicine It is important that all organisations which can reach and advocate for these groups should be invited to become involved in the PSP. The JLA will take responsibility for ensuring the various stakeholder groups are able to contribute equally to the process. Organisations wishing to participate in the PSP will be asked to affiliate to the JLA in order to demonstrate their commitment to the aims and values of the JLA. Details on the affiliation procedure can be found at www.lindalliance.org. Exclusion criteria Some organisations may be judged by the JLA or the Steering Group to have conflicts of interest. These may be perceived to adversely affect those organisations views, causing unacceptable bias. As this is likely to affect the ultimate findings of the PSP, those organisations will not be invited to participate. It is possible, however, that interested parties may participate in a purely observational capacity when the Steering Group considers it may be helpful. A paediatric emergency medicine research prioritisation exercise was recently undertaken by the Paediatric Emergency Research in the UK and Ireland (PERUKI) clinical studies group and published in the Emergency Medicine Journal (Hartshorn S, O Sullivan R, Maconochie IK, et al. Emerg Med J Published Online First: doi:10.1136/emermed-2014-204484). Paediatric emergency medicine will not therefore be considered during this PSP. METHODS This section describes a schedule of proposed stages through which the PSP aims to fulfil its objectives. The process is iterative and dependent on the active participation and contribution of different groups. The methods adopted in any stage with be agreed through consultation between the partners, guided by the PSP s aims and objectives. More details and examples can be found at www.jlaguidebook.org. 1. Identification and invitation of potential partners Potential partner organisations will be identified through a process of peer knowledge and consultation, through the Steering Group members networks and through the JLA s existing register of affiliates. Potential partners will be contacted and informed of the establishment and aims of the Emergency Medicine PSP and invited to participate. The Steering Group will draft the invitation specific to potential groups, and the invitation will be distributed through a variety of mechanisms including editorials in relevant journals, newsletters, emails and social media. 2. Initial stakeholder awareness raising The initial stakeholder awareness raising will have several key objectives: to welcome and introduce potential members of the Emergency Medicine PSP to present the proposed plan for the PSP to identify those potential partner organisations which will commit to the PSP and identify individuals who will be those organisations representatives and the PSP s principal contacts James Lind Alliance: Priority Setting Partnership Protocol 3

to establish principles upon which an open, inclusive and transparent mechanism can be based for contributing to, reporting and recording the work and progress of the PSP 3. Identifying treatment uncertainties Each partner organisation will identify a method for soliciting from its members questions and uncertainties of practical clinical importance relating to the treatment and management of patients within emergency departments. A period of 4 months will be given to complete this exercise. The methods may be designed according to the nature and membership of each organisation, but must be as transparent, inclusive and representative as practicable. Methods may include membership meetings (such as conferences), email consultation, postal or web-based questionnaires, internet message boards and focus group work. Existing sources of information about treatment uncertainties for patients and clinicians will be searched. These can include question-answering services for patients and carers and for clinicians; research recommendations in systematic reviews and clinical guidelines; protocols for systematic reviews being prepared and registers of ongoing research. The starting point for identifying sources of uncertainties and research recommendations is NHS Evidence: www.evidence.nhs.uk. 4. Refining questions and uncertainties The Steering Group will need to have agreed exactly who will be responsible for this stage the JLA can advise on the amount of time likely to be required for its execution. The JLA will participate in this process as an observer, to ensure accountability and transparency. The consultation process will produce raw unanswered questions about diagnosis and the effects of treatments. These raw questions will be assembled and categorised and refined by the steering group into collated indicative questions which are clear, addressable by research and understandable to all. Similar or duplicate questions will be combined where appropriate. The existing literature will be researched by a group of academic emergency medicine trainees, potentially assisted by a data analyst depending on the workload, to see to what extent these refined questions have, or have not, been answered by previous research. Sometimes, uncertainties are expressed that can in fact be resolved with reference to existing research evidence - ie they are "unrecognised knowns" and not uncertainties. If a question about treatment effects can be answered with existing information but this is not known, it suggests that information is not being communicated effectively to those who need it. Accordingly, the JLA recommends strongly that PSPs keep a record of these 'answerable questions' and deal with them separately from the 'true uncertainties' considered during the research priority setting process. These answerable questions may form the basis of mini-systemic reviews or Best Evidence Topics (BestBETs) that, if in the appropriate format, could be submitted to the BestBETs database. Uncertainties which are not adequately addressed by previous research will be collated and prepared for entry into an Emergency Medicine section within the UK Database of Uncertainties about the Effects of Treatments (UK DUETs - www.library.nhs.uk/duets) by Sam McIntyre. This will ensure that the uncertainties have been actually checked to be uncertainties. This is the responsibility of the Steering Group, which will need to have agreed personnel and resources to carry this accountability. James Lind Alliance: Priority Setting Partnership Protocol 4

The data should be entered into UK DUETs on completion of the priority setting exercise, in order to ensure any updates or changes to the data have been incorporated beforehand. 5. Prioritisation interim and final stages The aim of the final stage of the priority setting process is to prioritise through consensus the identified uncertainties relating to emergency medicine. This will be carried out by members of the Steering Group and the wider partnership that represents patients and clinicians. The interim stage, to proceed from a long list of uncertainties to a shorter list (e.g. up to 20), may be carried out over email, whereby organisations consult their membership and choose and rank their top 10 most important uncertainties. The final stage, to reach, for example, 10 prioritised uncertainties, is likely to be conducted in a faceto-face meeting, using group discussions and plenary sessions. The methods used for this prioritisation process will be determined by consultation with the partner organisations and with the advice of the JLA. Methods which have been identified as potentially useful in this process include: adapted Delphi techniques; expert panels or nominal group techniques; consensus development conference; electronic nominal group and online voting; interactive research agenda setting and focus groups. The JLA will facilitate this process and ensure transparency, accountability and fairness. Participants will be expected to declare their interests in advance of this meeting. Findings and research It is anticipated that the findings of the Emergency Medicine PSP will be reported to funding and research agenda setting organisations such as the NIHR Evaluation, Trials and Studies Coordinating Centre (NETSCC), which includes the HTA Programme, and the MRC, as well as the major research funding charities. Steering Group members and partners are encouraged to develop the prioritised uncertainties into research questions, and to work to establish the research needs of those unanswered questions to use when approaching potential funders, or when allocating funding for research themselves, if applicable. Publicity As well as alerting funders, partners and Steering Group members are encouraged to publish the findings of the Emergency Medicine PSP using both internal and external communication mechanisms. The JLA may also capture and publicise the results, through descriptive reports of the process itself. This exercise will be distinct from the production of an academic paper, which the partners are also encouraged to do. It is intended to submit the findings of the PSP to the Emergency Medicine Journal for publication. However, production of an academic paper should not take precedence over publicising of the final results. James Lind Alliance: Priority Setting Partnership Protocol 5

Signed by the Steering Group The undersigned agree to follow the Emergency Medicine Priority Setting Protocol. Dr Jason Smith, Derriford Hospital Date: 17 November 2015 Richard Morley, The James Lind Alliance Date: 17 November 2015 Sam McIntyre, Royal College of Emergency Medicine Date: 16 November 2015 James Lind Alliance: Priority Setting Partnership Protocol 6